Exempt Chemical Preparations Under the Controlled Substances Act

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-372]

Exempt Chemical Preparations Under the Controlled Substances Act

AGENCY:

Drug Enforcement Administration, Department of Justice.

ACTION:

Order with opportunity for comment.

SUMMARY:

The applications for exempt chemical preparations received by the Drug Enforcement Administration (DEA) between August 30, 2021, and March 31, 2022, as listed below, were accepted for filing and have been approved or denied as indicated.

DATES:

Interested persons may file written comments on this order in accordance with 21 CFR 1308.23(e). Electronic comments must be submitted, and written comments must be postmarked, on or before October 31, 2022. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. eastern time on the last day of the comment period.

ADDRESSES:

To ensure proper handling of comments, please reference “Docket No. DEA-372” on all correspondence, including any attachments.

Electronic comments:

DEA encourages that all comments be submitted through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or to attach a file for lengthier comments. Please go to

http://www.regulations.gov

and follow the online instructions at that site for submitting comments. Upon completion of your submission you will receive a Comment Tracking Number for your comment. Please be aware that submitted comments are not instantaneously available for public view on

Regulations.gov.

If you have received a comment tracking number, your comment has been successfully submitted and there is no need to resubmit the same comment.

Paper comments:

Paper comments that duplicate the electronic submission are not necessary and are discouraged. Should you wish to mail a comment

in lieu of

an electronic comment, it should be sent via regular or express mail to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.

FOR FURTHER INFORMATION CONTACT:

Terrence L. Boos, Ph.D., Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362-8201.

SUPPLEMENTARY INFORMATION:

Posting of Public Comments

Please note that all comments received are considered part of the public record and made available for public inspection online at

http://

www.regulations.gov

and in the DEA's public docket. Such information includes personal identifying information (such as your name, address, etc.) voluntarily submitted by the commenter. The Freedom of Information Act applies to all comments received.

If you want to submit personal identifying information (such as your name, address, etc.) as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase “PERSONAL IDENTIFYING INFORMATION” in the first paragraph of your comment. You must also place all the personal identifying information you do not want posted online or made available in the public docket in the first paragraph of your comment and identify what information you want redacted.

If you want to submit confidential business information as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase “CONFIDENTIAL BUSINESS INFORMATION” in the first paragraph of your comment. You must also prominently identify confidential business information to be redacted within the comment.

Comments containing personal identifying information and confidential business information identified as directed above will generally be made publicly available in redacted form. If a comment has so much confidential business information that it cannot be effectively redacted, all or part of that comment may not be made publicly available. Comments posted to

http://www.regulations.gov

may include any personal identifying information (such as name, address, and phone number) included in the text of your electronic submission that is not identified as directed above as confidential.

An electronic copy of this document is available at

http://www.regulations.gov

for easy reference.

Legal Authority

Section 201 of the Controlled Substances Act (CSA) (21 U.S.C. 811) authorizes the Attorney General, by regulation, to exempt from certain provisions of the CSA certain compounds, mixtures, or preparations containing a controlled substance, if he finds that such compounds, mixtures, or preparations meet the requirements detailed in 21 U.S.C. 811(g)(3)(B).

1

The Drug Enforcement Administration (DEA) regulations at 21 CFR 1308.23 and 1308.24 further detail the criteria by which the DEA Assistant Administrator may exempt a chemical preparation or mixture from certain provisions of the CSA. The Assistant Administrator may, pursuant to 21 CFR 1308.23(f), modify or revoke the criteria by which exemptions are granted and modify the scope of exemptions at any time.

1

This authority has been delegated from the Attorney General to the DEA Administrator by 28 CFR 0.100, and subsequently redelegated to the Deputy Assistant Administrator pursuant to 28 CFR 0.104 and section 7 of the appendix to subpart R of part 0.

Exempt Chemical Preparation Applications Submitted Between August 30, 2021, and March 31, 2022

DEA received applications between August 30, 2021, and March 31, 2022, requesting exempt chemical preparation status detailed in 21 CFR 1308.23. Pursuant to the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart I below is intended for laboratory, industrial, educational, or special research purposes and not for general administration to a human being or animal and either: (1) contains no narcotic controlled substance and is packaged in such a form or concentration that the packaged quantity does not present any significant potential for abuse; or (2) contains either a narcotic or non-narcotic controlled substance and one or more adulterating or denaturing agents in such a manner, combination, quantity, proportion, or concentration that the preparation or mixture does not present any potential for abuse and, if the preparation or mixture contains a narcotic controlled substance, is formulated in such a manner that it incorporates methods of denaturing or other means so that the preparation or mixture is not liable to be abused or have ill effects, if abused, and so that the narcotic substance cannot in practice be removed.

Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23, and 21 CFR 1308.24, the Assistant Administrator has determined that each of the chemical preparations or mixtures generally described in Chart I below and specifically described in the application materials received by DEA is exempt, to the extent described in 21 CFR 1308.24, from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 (21 U.S.C. 822-823, 825-829, and 952-954) of the CSA, and 21 CFR 1301.74, as of the date that was provided in the approval letters to the individual requesters.

Scope of Approval

The exemptions are applicable only to the precise preparation or mixture described in the application submitted to DEA in the form(s) listed in this order and only for those above mentioned sections of the CSA and the CFR. In accordance with 21 CFR 1308.24(h), any change in the quantitative or qualitative composition of the preparation or mixture, or change in the trade name or other designation of the preparation or mixture after the date of application requires a new application. The requirements set forth in 21 CFR 1308.24(b)-(e) apply to the exempted materials. In accordance with 21 CFR 1308.24(g), DEA may prescribe requirements other than those set forth in 21 CFR 1308.24(b)-(e) on a case-by-case basis for materials exempted in bulk quantities. Accordingly, in order to limit opportunity for diversion from the larger bulk quantities, DEA has determined that each of the exempted bulk products listed in this order may only be used in-house by the manufacturer, and may not be distributed for any purpose, or transported to other facilities.

Additional exempt chemical preparation requests received between August 30, 2021, and March 31, 2022, and not otherwise referenced in this order, may remain under consideration until DEA receives additional information required, pursuant to 21 CFR 1308.23(d), as detailed in separate correspondence to individual requesters. DEA's order on such requests will be communicated to the public in a future

Federal Register

publication.

DEA also notes that these exemptions are limited to exemption from only those sections of the CSA and the CFR that are specifically identified in 21 CFR 1308.24(a). All other requirements of the CSA and the CFR apply, including registration as an importer as required by 21 U.S.C. 957.

Chart I

Supplier

Product name

Form

Application

date

Aalto Scientific, Ltd

Unassayed Chemistry Base Level 1

Glass or plastic bottle or flask: 1mL-100 mL; 100mL-500mL; 500mL-1L

3/28/2022

Aalto Scientific, Ltd

Unassayed Chemistry Base Level 2

Glass or plastic bottle or flask: 1mL-100 mL; 100mL-500mL; 500mL-1L

3/28/2022

Aalto Scientific, Ltd

Unassayed Chemistry Base Level 3

Glass or plastic bottle or flask: 1mL-100 mL; 100mL-500mL; 500mL-1L

3/28/2022

Absolute Standards, Inc

(-)-Δ8-THC-D3, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

(-)-Δ9-THC-D3, 100 ug/mL, in Ethanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

(-)-Δ9-THC-D3, 1000 ug/mL, in Ethanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

(+/-)-11-Hydroxy-Δ9-THC-D3, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

(+/-)-11-Hydroxy-Δ9-THC-D3, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

(+/-)-Amphetamine-D8, 10 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

(+/-)-Amphetamine-D8, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

(+/-)-Amphetamine-D8, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

(+/-)-Methamphetamine-D8, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

(+/-)-Methamphetamine-D8, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

(+/-)-Methamphetamine-D9, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

AB-CHMINACA, 100 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

AB-FUBINACA, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

AB-PINACA, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

AH-7921, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

AKB48 (APINACA), 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

alpha-Pyrrolidinobutiophenone (alpha-PBP), 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

AM2201, 100 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

AM2201, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Benzoylecgonine, 10 ug/ml, in Methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Benzoylecgonine, 100 ug/ml, in Methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Benzoylecgonine, 1000 ug/ml, in Methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Benzoylecgonine-D8, 100 ug/ml, in Methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Benzoylecgonine-D8, 1000 ug/ml, in Methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Cocaine-D3, 10 ug/ml, in Methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Cocaine-D3, 100 ug/ml, in Methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Cocaine-D3, 1000 ug/ml, in Methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Codeine-6-β-glucuronide, 10 ug/ml, in acetonitrile:water [1:1]

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Codeine-6-β-glucuronide, 100 ug/ml, in acetonitrile:water [1:1]

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Codeine-6-β-glucuronide, 1000 ug/ml, in acetonitrile:water [1:1]

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

d,l-MDEA, 10 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

d,l-MDEA, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

d,l-MDEA, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

d,l-Methadone, 10 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

d,l-Methadone, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

d,l-Methadone, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

d,l-Methadone-D3, 10 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

d,l-Methadone-D3, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

d,l-Methadone-D3, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

DBP Mix, 100 ug/ml, in MTBE

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

DBP Mix, 100 ug/ml, in MTBE

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Dimethyltryptamine, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Dimethyltryptamine, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

d-Propoxyphene, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

d-Propoxyphene, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Ecognine methyl ester, 10 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Ecognine methyl ester, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Ecognine methyl ester, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

EPA Method 551 “Mix B”, 1000 ug/ml, in MTBE

Glass ampoule: 1 ml x 5

1/10/2022

Absolute Standards, Inc

EPA Method 551—Disinfection By-Products Mix #2, 100 ug/ml, in MTBE

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

EPA Method 551.1—Analytes Mix #2, 100 ug/ml, in MTBE

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Fenproporex, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Fenproporex-D5, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

FUB-144, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

FUB-AKB48 (FUB-APINACA), 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Heroin-D9, 10 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Heroin-D9, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Heroin-D9, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Hydrocodone (+)-bitartrate salt, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Hydrocodone (+)-bitartrate salt, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Hydrocodone, 10 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Hydrocodone, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Hydrocodone, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Hydromorphone, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Hydromorphone, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

JWH-019, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

JWH-073, 100 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

JWH-073, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

JWH-081, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

JWH-122, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

JWH-200, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

JWH-200-d5, 100 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

JWH-250, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Ketamine, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Ketamine, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Ketamine-D4, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Lysergic acid diethylamide (LSD), 100 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Lysergic acid diethylamide (LSD), 100 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Lysergic acid diethylamide (LSD), 1000 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Lysergic acid diethylamide (LSD), 1000 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Meperidine, 10 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Meperidine, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Meperidine, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Mephedrone, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Mephedrone, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Mix A, 1000 ug/ml, in MTBE

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

MMB-FUBINACA, 100 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

MMB-FUBINACA, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Nitrazepam, 100 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Nitrazepam, 1000 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

NM2201, 100 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Oxazepam, 10 ug/ml, in acetonitrile

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Oxazepam, 10 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Oxazepam, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Oxazepam, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Oxycodone, 10 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Oxycodone, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Oxycodone, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Oxycodone-D3, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Oxycodone-D3, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Oxycodone-D6, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Oxycodone-D6, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Oxymorphone, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Oxymorphone, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Oxymorphone-D3, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Oxymorphone-D3, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

PB-22, 100 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Phencyclidine-D5, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Phencyclidine-D5, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Phenylacetone, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Pregabalin, 10 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Pregabalin, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Pregabalin, 1000 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Psilocin, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Psilocin, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Psilocybin PT, varied ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

RCS-4, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

THC-O-acetate, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

THC-O-acetate, 1000 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

THC-O-acetate, varied ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Tramadol, 10 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

Tramadol, 100 ug/ml, in methanol

Glass ampoule: 1 ml

1/10/2022

Absolute Standards, Inc

UR-144, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

XLR-11, 100 ug/mL, in Methanol

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Zopiclone, 100 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Absolute Standards, Inc

Zopiclone, 1000 ug/mL, in Acetonitrile

Glass ampoule: 1 mL

2/14/2022

Audit MicroControls, Inc

Control FLQ Unassayed Chemistry, Level 1

Kit: 10 bottles, 4 mL each

3/30/2022

Audit MicroControls, Inc

Control FLQ Unassayed Chemistry, Level 1

Kit: 5 bottles, 4 mL each

3/30/2022

Audit MicroControls, Inc

Control FLQ Unassayed Chemistry, Level 1

Plastic bottle: 4mL

3/30/2022

Cerilliant Corporation

(6aR,9R)-delta10-THC

Glass ampule: 1.0 mL

8/30/2021

Cerilliant Corporation

5 Part Potency in Beverage

Glass ampule: 1.0 mL

2/22/2022

Cerilliant Corporation

6 Part Potency in Solution (Acids)

Glass ampule: 1.0 mL

1/11/2022

Cerilliant Corporation

8 Part Potency in Solution (Neutrals)

Glass ampule: 1.0 mL

1/11/2022

Chemtos, LLC

(S)-N,N-dimethylamphetamine HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

(S)-N,N-dimethylamphetamine-d3 HCl (0.1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

(S)-N,N-dimethylamphetamine-d3 HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

2,4-DMMC HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

3,4-DMMC HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

3-MMC HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

4-Cl-PVP HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

4-Methylbuphedrone (4-Me-MABP) HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

5F-MDMB-PICA (1 mg/mL in acetonitrile)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

AB-CHMINACA (1 mg/mL in acetonitrile)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

AB-PINACA (1 mg/mL in acetonitrile)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

alpha-PHP HBr (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Alphaprodine HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Alphaprodine-d5 HCl (0.1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Alphaprodine-d5 HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

AM-694 (1 mg/mL in acetonitrile)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Anileridine HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

APINACA, AKB48 (1 mg/mL in acetonitrile)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

bk-MDDMA HCl (Dimethylone) (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Diethyltryptamine (DET) (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Dimethyltryptamine (DMT) (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Dimethyltryptamine-d3 (DMT-d3) (0.1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Dimethyltryptamine-d3 (DMT-d3) (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Dipentylone HCl (bk-DMBDP) (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Estazolam (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Estazolam-d5 (0.1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Estazolam-d5 (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Flunitrazepam (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Flunitrazepam-d3 (0.1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Flunitrazepam-d3 (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Ketamine HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Ketamine-d4 HCl (0.1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Ketamine-d4 HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

MAB-CHMINACA (1 mg/mL in acetonitrile)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

MDMB-CHMICA, MMB-CHMINACA (1 mg/mL in acetonitrile)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

MMB-CHMICA, AMB-CHMICA (1 mg/mL in acetonitrile)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

MPHP HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Naphyrone HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

N-Ethyl-amphetamine HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

N-Ethyl-amphetamine-d5 HCl (0.1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

N-ethylhexedrone (NEH) HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

N-ethylhexedrone-d5 (NEH-d5) HCl (0.1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

NM2201, CBL-2201 (1 mg/mL in acetonitrile)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

PCC (1 mg/mL in acetonitrile)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Phendimetrazine-d8 (0.1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Phendimetrazine-d8 (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Phenylacetone (1 mg/mL in acetonitrile)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Propylone HCl (bk-3,4-MDPA) (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

PV8 (PHPP) HCl (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

Tenocyclidine (TCP) (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

Chemtos, LLC

THJ-2201 (AM2201) (1 mg/mL in methanol)

Amber ampule: 1 mL

3/14/2022

CPI International

Custom Hormone Mix, 9-072, 1000 mg/L, 1 mL (ISO 17025)

Amber ampule: 1 mL

2/2/2022

LabSystems Diagnostics

NeoMass CAH Extraction Solution with Internal Standard

Glass vial: 33 mL

1/10/2022

LabSystems Diagnostics

NeoMass CAH Mutlilevel Calibrator Dried Blood Spot Calibrator Level 0-7

Aluminum pouch: 7 Dried blood spots, 85 µL each

1/10/2022

LabSystems Diagnostics

NeoMass CAH Mutlilevel Controls Dried Blood Spot Controls Level 1-3

Aluminum pouch: 6 Dried blood spots, 85 µL each

1/10/2022

LabSystems Diagnostics

NeoMass CAH System suitability Mixture CAH (lyophilized)

Glass vial: 2 mL

1/10/2022

LabSystems Diagnostics

NeoMass CAH Tuning Mixture CAH (lyophilized)

Glass vial: 2 mL

1/10/2022

LGC

Narcotics Mixture 1 0.02-0.075 μg/mL in Synthetic oral fluid

1 kit; 10 × 1 mL amber cryule

3/8/2022

LGC

Narcotics Mixture 2 0.01-0.05 μg/mL in Synthetic oral fluid

1 kit; 10 × 1 mL amber cryule

3/8/2022

LGC

Narcotics Mixture 3 0.001-0.01 μg/mL in Synthetic oral fluid

1 kit; 10 × 1 mL amber cryule

3/8/2022

LGC—Dr. Ehrenstorfer

(6aR,9R)-Δ10-Tetrahydrocannabinol 100 μg/mL in Methanol

Amber Ampule: 1 mL

12/21/2021

LGC—Dr. Ehrenstorfer

(6aR-trans)-Δ8-Tetrahydrocannabinol acetate 100 μg/mL in Methanol

Amber Ampule: 1 mL

12/21/2021

LGC—Dr. Ehrenstorfer

Custom Cannabinoid Mixture 10141 1000 ug/mL in Acetonitrile

Amber ampule: 1 mL

3/4/2022

LGC—Dr. Ehrenstorfer

Custom Cannabinoid Mixture 10142 1000 ug/mL in Acetonitrile

1 kit; 5 × 1 mL amber ampule

3/4/2022

LGC—Dr. Ehrenstorfer

Custom Pharmaceutical Mixture 10147 1000 ug/mL in Acetonitrile

Amber ampule: 1 mL

3/4/2022

LGC—Dr. Ehrenstorfer

Custom Pharmaceutical Mixture 10148 1000 ug/mL in Acetonitrile

1 kit; 5 × 1 mL amber ampule

3/4/2022

LGC—Dr. Ehrenstorfer

Custom Tramadol hydrochloride 100 μg/mL in Methanol

Glass Ampule: 1 mL

1/27/2022

LGC—Dr. Ehrenstorfer

Trenbolone cyclohexylmethylcarbonate 100 μg/mL in Acetonitrile

Amber Ampule: 1 mL

12/21/2021

LGC—Dr. Ehrenstorfer

Zolpidem tartrate 100 μg/mL in Methanol

Glass Ampule: 1 mL

1/27/2022

LGC Clinical Diagnostics, Inc

Fertility 1 ab Bulk—Level 1

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Fertility 1 ab Bulk—Level 2

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Fertility 1 ab Bulk—Level 3

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Fertility 1 ab Bulk—Level 4

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Fertility 1 ab Bulk—Level 5

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Fertility 1 ab WrkBlk—Level 1

Volumetric flask: 200-8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Fertility 1 ab WrkBlk—Level 5

Volumetric flask: 200-8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Fertility 1 re Bulk—Level 1

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Fertility 1 re Bulk—Level 2

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Fertility 1 re Bulk—Level 3

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Fertility 1 re Bulk—Level 4

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Fertility 1 re Bulk—Level 5

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Fertility 1 re WrkBlk—Level 1

Volumetric flask: 200-8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Fertility 1 re WrkBlk—Level 5

Volumetric flask: 200-8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ab Bulk—Level 1

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ab Bulk—Level 2

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ab Bulk—Level 3

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ab Bulk—Level 4

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ab Bulk—Level 5

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ab WrkBlk—Level 1

Volumetric flask: 200-8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 au Bulk—Level 1

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 au Bulk—Level 2

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 au Bulk—Level 3

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 au Bulk—Level 4

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 au Bulk—Level 5

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 au WrkBlk—Level 1

Volumetric flask: 200-8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 bc Bulk—Level 1

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 bc Bulk—Level 2

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 bc Bulk—Level 3

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 bc Bulk—Level 4

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 bc Bulk—Level 5

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 bc WrkBlk—Level 1

Volumetric flask: 200-8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 db Bulk—Level 1

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 db Bulk—Level 2

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 db Bulk—Level 3

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 db Bulk—Level 4

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 db Bulk—Level 5

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 db WrkBlk—Level 1

Volumetric flask: 200-8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri GentC Set Bulk—Level 1

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri GentC Set Bulk—Level 2

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri GentC Set Bulk—Level 3

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri GentC Set Bulk—Level 4

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri GentC Set Bulk—Level 5

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri GentC Set WrkBlk—Level 1

Volumetric flask: 200-8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri TDM Set Bulk—Level 1

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri TDM Set Bulk—Level 2

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri TDM Set Bulk—Level 3

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri TDM Set Bulk—Level 4

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri TDM Set Bulk—Level 5

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri TDM Set WrkBlk—Level 1

Volumetric flask: 200-8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 vt Set Bulk—Level 1

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 vt Set Bulk—Level 2

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 vt Set Bulk—Level 3

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 vt Set Bulk—Level 4

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 vt Set Bulk—Level 5

Volumetric flask: 3200 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 vt Set WrkBlk—Level 1

Volumetric flask: 200-8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Testosterone (TSTO) Stock A 100,000 ng/ml

Plastic vial: 25 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Testosterone (TSTO) Stock B 2,000 ng/ml

Plastic vial: 25 mL

3/21/2022

LGC Clinical Diagnostics, Inc

VALIDATE Fertility 1 Test Set 502ab

5 Bottles: 4 mL each

3/21/2022

LGC Clinical Diagnostics, Inc

VALIDATE Fertility 1 Test Set 502re

5 Bottles: 4 mL each

3/21/2022

LGC Clinical Diagnostics, Inc

VALIDATE TDM1 Test Set 301ab

Kit: 5 Bottles, 3 ml each

3/21/2022

LGC Clinical Diagnostics, Inc

VALIDATE TDM1 Test Set 301au

Kit: 5 Bottles, 3 ml each

3/21/2022

LGC Clinical Diagnostics, Inc

VALIDATE TDM1 Test Set 301bc

Kit: 5 Bottles, 3 ml each

3/21/2022

LGC Clinical Diagnostics, Inc

VALIDATE TDM1 Test Set 301db

Kit: 5 Bottles, 3 ml each

3/21/2022

LGC Clinical Diagnostics, Inc

VALIDATE TDM1 Test Set 301ri

Kit: 5 Bottles, 3 ml each; 5 bottles, 2 mL each

3/21/2022

LGC Clinical Diagnostics, Inc

VALIDATE TDM1 Test Set 301vt

Kit: 5 Bottles, 3 ml each

3/21/2022

o2si smart solutions

Custom Pharmaceutical Mixture, 12-0370, 100 ug/mL, 5 × 1 mL (ISO 17034)

1 Package; 5 × 1 mL amber ampules

1/14/2022

o2si smart solutions

Hydrocodone hydrogen (+)-bitartrate as hydrocodone in acetonitrile Solution, 5,000 mg/L PARENT STOCK SOLUTION—NOT FOR SALE

Amber ampule: 1 mL

2/11/2022

Restek Corporation

Custom Heroin Standard

Glass ampule: 1.3 mL

3/8/2022

RTI International

12198-62-06

Glass tube: 7 mL

3/1/2022

RTI International

2023 DMPM-01

HDPE Bottle: 40 mL

3/30/2022

RTI International

2023 DMPM-02

HDPE Bottle: 40 mL

3/30/2022

RTI International

2023 DMPM-03

HDPE Bottle: 40 mL

3/30/2022

RTI International

2023 DMPM-05

HDPE Bottle: 40 mL

3/30/2022

RTI International

2023 DMPM-06

HDPE Bottle: 40 mL

3/30/2022

RTI International

2023 DMPM-07

HDPE Bottle: 40 mL

3/30/2022

RTI International

2023 FTC-02

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 FTC-03

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 FTC-05

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 FTC-06

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 FTC-07

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 FTC-09

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 FTC-10

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 FTC-11

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 FTC-13

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 FTC-14

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 FTC-15

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 OFD-01

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-02

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-03

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-04

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-05

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-06

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-07

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-08

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-10

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-11

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-12

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-13

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-14

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-15

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-16

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-17

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-18

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-19

Vial: 2 mL

3/30/2022

RTI International

2023 OFD-20

Vial: 2 mL

3/30/2022

RTI International

2023 T-02

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 T-03

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 T-04

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 T-05

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 T-06

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 T-07

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 T-08

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 T-11

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 T-12

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 T-14

HDPE Bottle: 20 mL

3/30/2022

RTI International

2023 THCB-01

Vial: 10 mL

3/30/2022

RTI International

2023 THCB-02

Vial: 10 mL

3/30/2022

RTI International

2023 THCB-03

Vial: 10 mL

3/30/2022

RTI International

2023 THCB-04

Vial: 10 mL

3/30/2022

RTI International

2023 THCB-05

Vial: 10 mL

3/30/2022

RTI International

2023 THCB-06

Vial: 10 mL

3/30/2022

RTI International

2023 UDS-01

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-02

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-03

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-04

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-05

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-06

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-07

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-08

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-09

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-10

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-11

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-12

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-13

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-14

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UDS-15

HDPE Bottle: 10 mL

3/30/2022

RTI International

2023 UT-01

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UT-02

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UT-03

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UT-05

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UT-06

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UT-07

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UT-08

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UT-09

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UT-10

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UT-11

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UT-12

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UT-13

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UT-14

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UT-15

HDPE Bottle: 50 mL

3/30/2022

RTI International

2023 UTCO-01

HDPE Bottle: 40 mL

3/30/2022

RTI International

2023 ZE-01

Vial: 5 mL

3/30/2022

RTI International

2023 ZE-02

Vial: 5 mL

3/30/2022

RTI International

2023 ZE-03

Vial: 5 mL

3/30/2022

RTI International

2023 ZE-04

Vial: 5 mL

3/30/2022

RTI International

2023 ZE-05

Vial: 5 mL

3/30/2022

RTI International

2023 ZE-06

Vial: 5 mL

3/30/2022

RTI International

2023-OFD-09

Vial: 2 mL

3/30/2022

RTI International

Sample 1 Matrix: Urine

HDPE tubes: 5 mL

3/7/2022

RTI International

Sample 2 Matrix: Urine

HDPE tubes: 5 mL

3/7/2022

RTI International

Sample 3 Matrix: Plasma

HDPE tubes: 5 mL

3/7/2022

RTI International

Sample 4 Matrix: Urine

HDPE tubes: 5 mL

3/7/2022

RTI International

Sample 6 Matrix: Whole Blood

HDPE tubes: 5 mL

3/7/2022

Thermo Fisher Scientific

Cascadion SM Antiepileptics Internal Standard

Box: 6 vials, 29 mL each

3/24/2022

The Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart II below is not consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23. Accordingly, the Assistant Administrator has determined that the chemical preparations or mixtures generally described in Chart II below and specifically described in the application materials received by DEA, are not exempt from application of any part of the CSA or from application of any part of the CFR, with regard to the requested exemption pursuant to 21 CFR 1308.23, as of the date that was provided in the determination letters to the individual requesters.

Chart II

Supplier

Product name

Form

Application

date

Chemtos, LLC

ANPP (1 mg/mL in acetonitrile)

Amber ampule: 1mL

3/14/2022

CPI International

Custom Hormone Mix, 9-072, 1000 mg/L, 6 x 1 ml

1 Package; 6 x 1 mL amber ampules

1/14/2022

LGC Clinical Diagnostics, Inc

TDM1 ab WrkBlk—Level 5

Volumetric flask: 200—8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 au WrkBlk—Level 5

Volumetric flask: 200—8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 bc WrkBlk—Level 5

Volumetric flask: 200—8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 db WrkBlk—Level 5

Volumetric flask: 200—8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri GentC Set WrkBlk—Level 5

Volumetric flask: 200—8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 ri TDM Set WrkBlk—Level 5

Volumetric flask: 200—8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

TDM1 vt Set WrkBlk—Level 5

Volumetric flask: 200—8000 mL

3/21/2022

LGC Clinical Diagnostics, Inc

Validate TDM Phenobarbital Stock

Plastic vial: 150 mL

3/21/2022

Opportunity for Comment

Pursuant to 21 CFR 1308.23(e), any interested person may submit written comments on or objections to any chemical preparation in this order that has been approved or denied as exempt. If any comments or objections raise significant issues regarding any finding of fact or conclusion of law upon which this order is based, the Assistant Administrator will immediately suspend the effectiveness of any applicable part of this order until she may reconsider the application in light of the comments and objections filed. Thereafter, the Assistant Administrator shall reinstate, revoke, or amend his original order as she determines appropriate.

Approved Exempt Chemical Preparations are Posted on the DEA's Website

A list of all current exemptions, including those listed in this order, is available on the DEA's website at

http://www.DEAdiversion.usdoj.gov/schedules/exempt/exempt_chemlist.pdf.

The dates of applications of all current exemptions are posted for easy reference.

Kristi O'Malley,

Assistant Administrator.

[FR Doc. 2022-18794 Filed 8-30-22; 8:45 am]

BILLING CODE 4410-09-P